Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by PeterMacd2on Nov 04, 2019 1:41pm
141 Views
Post# 30306362

Irwin's strategy is the right one

Irwin's strategy is the right oneI said some weeks back that it could be that the only thing that will break the negative mindset of MMs re APHA is continued profitability and sales growth, long term. I.e. "Show Us the Money". It's becoming clearer that that is the case, and we can now see that MMs really have a perceptual mental block about this co. How many other companies in other industries would see a >1% sp DROP, on a day when a doubling in production capacity is announced?  Especially when on the same day failing cos like WEED, ACB, TRST, ad nauseum see sp RISES. We're still penalized while others get a free ride. There is also still a lot of misinformation around, esp among so-called "analysts". Those who think there is an over-supply issue re APHA haven't been paying attention; our flower is in high demand, & our oils extraction facility will eat up all the supply we can put out. Then there's the forthcoming EU market. One problem is most MMs and analysts are American-based, and they generally give little thought to the size of the EU and CDN markets - for anything.

So today, on such a disappointing day it's important to remember Irwin's clearly stated strategy to achieve a breakthough, which differentiates us from the others. This from today's news release:
“We believe the introduction of our proprietary automation technology at Aphria Diamond will provide us with the ability to cultivate high-quality cannabis with great efficiency and at an unprecedented scale,” continued Simon. “As we remain focused on sales growth and profitability, this unique advantage is expected to enable Aphria to continue to create long-term value ...". 
Eventually, lowest cost, high volume, high quality product will win out.
Bullboard Posts